Cargando…
Distribution of (14)C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration
PURPOSE: To qualitatively evaluate the ocular and periocular distribution of (14)C-latanoprost following a single intracameral administration or repeated topical ocular administration in beagle dogs and cynomolgus monkeys. METHODS: In the dog study, three animals received an intracameral dose of (14...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708611/ https://www.ncbi.nlm.nih.gov/pubmed/32740740 http://dx.doi.org/10.1007/s40123-020-00285-3 |
_version_ | 1783617574135660544 |
---|---|
author | Shen, Jie Moats, Rex A. Pollack, Harvey A. Robinson, Michael R. Attar, Mayssa |
author_facet | Shen, Jie Moats, Rex A. Pollack, Harvey A. Robinson, Michael R. Attar, Mayssa |
author_sort | Shen, Jie |
collection | PubMed |
description | PURPOSE: To qualitatively evaluate the ocular and periocular distribution of (14)C-latanoprost following a single intracameral administration or repeated topical ocular administration in beagle dogs and cynomolgus monkeys. METHODS: In the dog study, three animals received an intracameral dose of (14)C-latanoprost bilaterally and were euthanized at 1, 2, and 4 h post dose; three control animals received topical (14)C-latanoprost bilaterally once daily for 5 days and were euthanized at 1, 4, and 24 h post final dose. Sagittal 40-µm sections of eyes with surrounding tissues were collected and processed for autoradiography. Methods in the monkey study were similar; two animals received a unilateral intracameral dose of (14)C-latanoprost. RESULTS: After intracameral dosing in dogs, radioactivity was concentrated in the cornea, iris, ciliary body, and anterior chamber with no radioactivity detected in the eyelids or other periorbital tissues. After topical dosing, radioactivity was distributed in the bulbar conjunctiva, cornea, anterior chamber, iris, ciliary body, upper and lower eyelids, and periorbital tissues (fat/muscle). After intracameral dosing in monkeys, radioactivity was concentrated in the anterior chamber, cornea, iris, ciliary body, and posteriorly along the uveoscleral outflow pathway; there was no radioactivity in the eyelids or periorbital tissues aside from signal in the nasolacrimal duct, likely from reflux of (14)C-latanoprost into the tear film. CONCLUSIONS: Intracameral delivery resulted in more selective target tissue drug exposure. Intracameral drug delivery has potential to reduce ocular surface and periocular adverse effects associated with topical administration of prostaglandin analogues, such as eyelash growth and periorbital fat atrophy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40123-020-00285-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7708611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-77086112020-12-04 Distribution of (14)C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration Shen, Jie Moats, Rex A. Pollack, Harvey A. Robinson, Michael R. Attar, Mayssa Ophthalmol Ther Original Research PURPOSE: To qualitatively evaluate the ocular and periocular distribution of (14)C-latanoprost following a single intracameral administration or repeated topical ocular administration in beagle dogs and cynomolgus monkeys. METHODS: In the dog study, three animals received an intracameral dose of (14)C-latanoprost bilaterally and were euthanized at 1, 2, and 4 h post dose; three control animals received topical (14)C-latanoprost bilaterally once daily for 5 days and were euthanized at 1, 4, and 24 h post final dose. Sagittal 40-µm sections of eyes with surrounding tissues were collected and processed for autoradiography. Methods in the monkey study were similar; two animals received a unilateral intracameral dose of (14)C-latanoprost. RESULTS: After intracameral dosing in dogs, radioactivity was concentrated in the cornea, iris, ciliary body, and anterior chamber with no radioactivity detected in the eyelids or other periorbital tissues. After topical dosing, radioactivity was distributed in the bulbar conjunctiva, cornea, anterior chamber, iris, ciliary body, upper and lower eyelids, and periorbital tissues (fat/muscle). After intracameral dosing in monkeys, radioactivity was concentrated in the anterior chamber, cornea, iris, ciliary body, and posteriorly along the uveoscleral outflow pathway; there was no radioactivity in the eyelids or periorbital tissues aside from signal in the nasolacrimal duct, likely from reflux of (14)C-latanoprost into the tear film. CONCLUSIONS: Intracameral delivery resulted in more selective target tissue drug exposure. Intracameral drug delivery has potential to reduce ocular surface and periocular adverse effects associated with topical administration of prostaglandin analogues, such as eyelash growth and periorbital fat atrophy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40123-020-00285-3) contains supplementary material, which is available to authorized users. Springer Healthcare 2020-08-01 2020-12 /pmc/articles/PMC7708611/ /pubmed/32740740 http://dx.doi.org/10.1007/s40123-020-00285-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research Shen, Jie Moats, Rex A. Pollack, Harvey A. Robinson, Michael R. Attar, Mayssa Distribution of (14)C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration |
title | Distribution of (14)C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration |
title_full | Distribution of (14)C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration |
title_fullStr | Distribution of (14)C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration |
title_full_unstemmed | Distribution of (14)C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration |
title_short | Distribution of (14)C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration |
title_sort | distribution of (14)c-latanoprost following a single intracameral administration versus repeated topical administration |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708611/ https://www.ncbi.nlm.nih.gov/pubmed/32740740 http://dx.doi.org/10.1007/s40123-020-00285-3 |
work_keys_str_mv | AT shenjie distributionof14clatanoprostfollowingasingleintracameraladministrationversusrepeatedtopicaladministration AT moatsrexa distributionof14clatanoprostfollowingasingleintracameraladministrationversusrepeatedtopicaladministration AT pollackharveya distributionof14clatanoprostfollowingasingleintracameraladministrationversusrepeatedtopicaladministration AT robinsonmichaelr distributionof14clatanoprostfollowingasingleintracameraladministrationversusrepeatedtopicaladministration AT attarmayssa distributionof14clatanoprostfollowingasingleintracameraladministrationversusrepeatedtopicaladministration |